Catheter PrecisionVTAK +30.98%28 Market Cap is $3.24 Mil as of Jun. 24, 2026. GuruFocus rates VTAK with a GF Score™ of 28/100 and a GF Value™ of $1.72 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Catheter Precision ranks worse than 95.84% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Catheter Precision's share price for the quarter that ended in Mar. 2026 was $1.01. Catheter Precision's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 2.69 Mil. Therefore, Catheter Precision's market cap for the quarter that ended in Mar. 2026 was $2.72 Mil.
Catheter Precision's quarterly market cap
declined
from Sep. 2025 ($4.15 Mil) to Dec. 2025 ($3.18 Mil) and
declined
from Dec. 2025 ($3.18 Mil) to Mar. 2026 ($2.72 Mil).
Catheter Precision's annual market cap
increased
from Dec. 2023 ($2.84 Mil) to Dec. 2024 ($3.61 Mil) but then
declined
from Dec. 2024 ($3.61 Mil) to Dec. 2025 ($3.18 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Catheter Precision's Enterprise Value for Today is $14.38 Mil.
Catheter Precision (AMEX:VTAK) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Catheter Precision Market Cap Related Terms
Catheter Precision Market Cap Historical Data
* Premium members only.
The historical data trend for Catheter Precision's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Catheter Precision's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Catheter Precision Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's Market Cap distribution charts can be found below:
* The bar in red indicates where Catheter Precision's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Catheter Precision's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Catheter Precision (VTAK) has a Market Cap of $3.24 Mil as of Jun. 24, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Catheter Precision and its competitors. According to the industry distribution chart, Catheter Precision ranks #830 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 95.8%.
Is Catheter Precision's Market Cap too high?
Catheter Precision's current Market Cap is $3.24 Mil. The Medical Devices & Instruments industry median Market Cap is 122.09. Catheter Precision's value of $3.24 Mil is 97.3% below this industry median. Based on the distribution chart, Catheter Precision ranks #830 out of 866 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Catheter Precision has a GF Score™ of 28/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Catheter Precision's Market Cap compare to VYCO and BJDX?
According to the Medical Devices & Instruments industry distribution chart, Catheter Precision ranks #830 out of 866 companies for Market Cap. This places Catheter Precision in the lower half of its industry. The industry median Market Cap is 122.09. Catheter Precision's value of $3.24 Mil is 97.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 122.09, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Catheter Precision's current Market Cap of $3.24 Mil is 97.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Catheter Precision and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 122.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Catheter Precision's current Market Cap is $3.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Catheter Precision stock overvalued right now?
Based on GuruFocus' analysis, Catheter Precision (VTAK) is currently considered Possible Value Trap. The stock's GF Value™ is $1.72, compared to a current price of $1.21 — trading 29.9% below its estimated fair value. The current Market Cap is $3.24 Mil and 97.3% below the Medical Devices & Instruments industry median of 122.09. Catheter Precision's overall GF Score™ is 28/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Catheter Precision (VTAK), the current Market Cap is $3.24 Mil as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Catheter Precision (VTAK) Overvalued in 2026?
Based on GuruFocus' analysis, Catheter Precision stock appears to be undervalued.
The current stock price of $1.21 is trading 29.9% below its estimated GF Value™ of $1.72.
GuruFocus considers Catheter Precision to be Possible Value Trap.
Key valuation signals for VTAK:
Market Cap: $3.24 Mil
GF Value™: $1.72 vs. price of $1.21 (29.9% below fair value)
Industry Position: 97.3% below the Medical Devices & Instruments median (#830 of 866)
No single metric tells the full story. See the VTAK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
28GF Score
Get the complete analysis for VTAK
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VTAK has been successfully added to your 
